201 related articles for article (PubMed ID: 15936336)
1. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
Viviano BL; Silverstein L; Pflederer C; Paine-Saunders S; Mills K; Saunders S
Dev Biol; 2005 Jun; 282(1):152-62. PubMed ID: 15936336
[TBL] [Abstract][Full Text] [Related]
2. Identification of multiple osteoclast precursor populations in murine bone marrow.
Jacquin C; Gran DE; Lee SK; Lorenzo JA; Aguila HL
J Bone Miner Res; 2006 Jan; 21(1):67-77. PubMed ID: 16355275
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice.
Blin-Wakkach C; Wakkach A; Rochet N; Carle GF
J Bone Miner Res; 2004 Jul; 19(7):1137-43. PubMed ID: 15176997
[TBL] [Abstract][Full Text] [Related]
4. Role of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis of bone marrow derived stem cells.
Bayoumy M; Sankar U; Muthusamy N
Indian J Exp Biol; 2002 Sep; 40(9):995-1000. PubMed ID: 12587726
[TBL] [Abstract][Full Text] [Related]
5. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
[TBL] [Abstract][Full Text] [Related]
6. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
[TBL] [Abstract][Full Text] [Related]
7. Role of CSF-1 in bone and bone marrow development.
Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
[TBL] [Abstract][Full Text] [Related]
8. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.
Paine-Saunders S; Viviano BL; Zupicich J; Skarnes WC; Saunders S
Dev Biol; 2000 Sep; 225(1):179-87. PubMed ID: 10964473
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.
Sasaki H; Yamamoto H; Tominaga K; Masuda K; Kawai T; Teshima-Kondo S; Matsuno K; Yabe-Nishimura C; Rokutan K
Free Radic Biol Med; 2009 Jul; 47(2):189-99. PubMed ID: 19409483
[TBL] [Abstract][Full Text] [Related]
10. Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification.
Kishida Y; Hirao M; Tamai N; Nampei A; Fujimoto T; Nakase T; Shimizu N; Yoshikawa H; Myoui A
Bone; 2005 Nov; 37(5):607-21. PubMed ID: 16039170
[TBL] [Abstract][Full Text] [Related]
11. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
Takahashi N
Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
[TBL] [Abstract][Full Text] [Related]
12. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
[TBL] [Abstract][Full Text] [Related]
14. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
[TBL] [Abstract][Full Text] [Related]
15. Perspective. Osteoclastogenesis and growth plate chondrocyte differentiation: emergence of convergence.
Odgren PR; Philbrick WM; Gartland A
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):181-93. PubMed ID: 14696966
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
17. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
18. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
[TBL] [Abstract][Full Text] [Related]
20. Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function.
Feng X; Takeshita S; Namba N; Wei S; Teitelbaum SL; Ross FP
Endocrinology; 2002 Dec; 143(12):4868-74. PubMed ID: 12446614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
